Carregant...

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key

Triple negative breast cancer (TNBC) accounts for 15%-20% of all breast cancer, and is still defined as what it is not. Currently, TNBC is the only type of breast cancer for which there are no approved targeted therapies and maximum tolerated dose chemotherapy with taxanes and anthracycline-containi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Clin Oncol
Autors principals: Rabanal, Connie, Ruiz, Rossana, Neciosup, Silvia, Gomez, Henry
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740099/
https://ncbi.nlm.nih.gov/pubmed/29291168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v8.i6.437
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!